HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,830.00
+30.00 (0.44%)
Nov 17, 2026, 3:30 PM KST

HLB Pharmaceutical Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2019FY 2018FY 2017
Period Ending
Sep '26 Dec '25 Dec '24 Dec '19 Dec '18 Dec '17
Cash & Equivalents
25,5347,60910,4922,7443,0305,350
Short-Term Investments
54,63814,52811,5001,310235525
Trading Asset Securities
---11,1095,8425,514
Cash & Short-Term Investments
80,17222,13721,99215,1639,10711,389
Cash Growth
187.62%0.66%45.04%66.50%-20.04%-
Accounts Receivable
25,47322,83316,0957,9106,0446,382
Other Receivables
1,2781,3951,408156.15163.97128.86
Receivables
26,75224,22717,5048,0666,2186,521
Inventory
33,38829,52622,8615,6485,3824,884
Prepaid Expenses
436.14151.11178.2547.26428.26242.13
Other Current Assets
1,417660.69845.6593.85140.41230.82
Total Current Assets
142,16576,70263,38129,01821,27523,267
Property, Plant & Equipment
44,25644,38834,02015,31513,30413,323
Long-Term Investments
61,06345,20455,078146.51,2651,789
Goodwill
105.07105.07----
Other Intangible Assets
5,0843,6704,448446.2282.13188.45
Long-Term Deferred Tax Assets
---208.276.991,002
Long-Term Deferred Charges
33.84185.53387.79629.76129.67-
Other Long-Term Assets
437.88428.28620.2782.12160.27277.32
Total Assets
253,145170,682157,93345,84636,42339,846

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2019FY 2018FY 2017
Period Ending
Sep '26 Dec '25 Dec '24 Dec '19 Dec '18 Dec '17
Accounts Payable
10,48610,2578,7182,4044,8562,261
Accrued Expenses
7,9176,6198,1334,5932,0922,241
Short-Term Debt
20,00015,00015,0008,4584,8541,725
Current Portion of Long-Term Debt
---7801,58010,388
Current Portion of Leases
1,5491,540763.8426.67--
Current Income Taxes Payable
----105.9-
Other Current Liabilities
4,8396,2126,0176,4292,7361,126
Total Current Liabilities
44,79139,62838,63223,09216,22417,741
Long-Term Debt
---1,5801,2602,840
Long-Term Leases
3,4624,144290.771,954--
Pension & Post-Retirement Benefits
2,2461,436937.151,1661,5212,375
Long-Term Deferred Tax Liabilities
1,673325.351,672-314.93-
Other Long-Term Liabilities
-00151.41105.7288.99
Total Liabilities
52,17245,53441,53227,94319,42523,045

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2019FY 2018FY 2017
Period Ending
Sep '26 Dec '25 Dec '24 Dec '19 Dec '18 Dec '17
Common Stock
21,78116,40015,9076,9246,9246,247
Additional Paid-In Capital
116,64961,98193,4338,43517,30415,263
Retained Earnings
57,45656,3681,9711,215-8,453-5,410
Treasury Stock
-5.6-5.6-5.6-5.6-5.6-5.6
Comprehensive Income & Other
5,093-9,5945,0961,3341,229707.13
Shareholders' Equity
200,972125,149116,40217,90316,99816,802
Total Liabilities & Equity
253,145170,682157,93345,84636,42339,846

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2019FY 2018FY 2017
Period Ending
Sep '26 Dec '25 Dec '24 Dec '19 Dec '18 Dec '17
Total Debt
25,01120,68416,05513,1987,69414,953
Net Cash (Debt)
55,1621,4535,9381,9651,413-3,564
Net Cash Growth
471.35%-75.53%202.18%39.05%--
Net Cash Per Share
1638.2644.45185.74141.88104.39-297.72
Filing Date Shares Outstanding
35.1532.831.8113.8513.8512.49
Total Common Shares Outstanding
35.1532.831.8113.8513.8512.49
Working Capital
97,37437,07324,7495,9275,0525,526
Book Value Per Share
5717.153815.653658.771292.831227.521344.92
Tangible Book Value
195,784121,374111,95417,45716,71616,613
Tangible Book Value Per Share
5569.553700.573518.981260.611207.151329.84
Land
26,79226,79226,7921,2391,2391,239
Buildings
2,1723,6973,6978,5208,4728,581
Machinery
16,52115,61615,7709,6738,7729,892
Construction In Progress
6,0786,5231,658382.9183.6136.94